These results show that miR-199a-3p regulates proliferation, adhesion, and invasiveness in ovarian cancer cells through the inhibition of c-Met expression and thus affects the expression of downstream proteins such as integrin β1, CD44, and MMP-2. Here, MET is linked to ovarian cancer.